Glow 70mg (R&D Only)

100.00

 

 

Technical Specifications
Parameter Specification
Product Name GLOW 70mg Research Peptide Blend
Composition GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg
Total Mass 70mg per vial
Form Lyophilized (freeze-dried) powder
Purity ≥98% per component (HPLC/MS verified)
CAS Numbers GHK-Cu: 49557-75-7
BPC-157: 137525-51-0
TB-500: 77591-33-4
Molecular Weight GHK-Cu: ~340.9 Da
BPC-157: 1419.5 Da
TB-500: 4963 Da
Sequence (GHK-Cu) Glycyl-L-histidyl-L-lysine-Cu(II)
Sequence (BPC-157) Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Sequence (TB-500) Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
Shelf Life (Lyophilized) 24 months when stored properly
Shipping Conditions Ambient temperature
Storage (Lyophilized) -20°C (-4°F) for long-term
Storage (Reconstituted) 2–8°C (35.6–46.4°F), use within 28 days

 

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Buy GLOW 70mg (R&D Only) – Synergistic Research Peptide Blend | BPC-157, TB-500 & GHK-Cu

The GLOW 70mg peptide blend represents a sophisticated research tool for investigators studying multi-pathway regenerative mechanisms. This synergistic formulation combines three extensively researched peptides into a single lyophilized preparation: GHK-Cu (Copper Tripeptide-1), BPC-157 (Body Protection Compound 157), and TB-500 (Thymosin Beta-4 fragment). Each component contributes distinct mechanisms of action, enabling researchers to explore combined effects on tissue repair, extracellular matrix remodeling, angiogenesis, and inflammation modulation. Buy GLOW 70mg research peptide Online

For research institutions and laboratories seeking buy peptides EU solutions, this ready-to-use blend eliminates the need for individual peptide sourcing and custom mixing, ensuring consistent ratios for reproducible experimental conditions. The 70mg total mass comprises 50mg GHK-Cu, 10mg TB-500, and 10mg BPC-157, a proportion validated in research protocols. Buy GLOW 70mg research peptide Online

This product is strictly for laboratory and scientific research use only. Not for human consumption. Visit our homepage at euresearchpeptides.com to explore our complete catalog of high purity peptides Germany and research chemicals EU compliant products.

Purity Specifications & Quality Assurance

Every batch of GLOW 70mg undergoes rigorous analytical testing to ensure research-grade quality:

  • HPLC Purity: ≥98% for each individual peptide component

  • Mass Spectrometry (MS): Verified molecular weight confirmation

  • Endotoxin Testing: <1.0 EU/mg

  • Residual Solvents: Meets ICH Class 3 limits

  • Bioburden: Sterile filtered, no microbial growth

Certificates of Analysis (COA) are available for each lot number, providing full transparency for laboratory peptides Netherlands and peptide supplier Spain research requirements.


Molecular Mechanisms of Action

GHK-Cu (Copper Tripeptide-1)

GHK-Cu functions as a genomic modulator, upregulating genes associated with tissue growth while downregulating inflammatory and tissue breakdown pathways. It stimulates collagen and glycosaminoglycan synthesis in fibroblasts, promotes angiogenesis through VEGF pathway activation, and exhibits antioxidant properties via superoxide dismutase (SOD) mimetic activity. The copper-bound tripeptide shifts TGF-β/SMAD and MMP/TIMP balance toward organized remodeling.

BPC-157 (Body Protection Compound 157)

BPC-157 modulates VEGFR2/nitric oxide signaling and the FAK-paxillin pathway, driving angiogenesis, cell migration, and tight-junction repair. It demonstrates anti-inflammatory effects through NF-κB restraint and enhances growth factor receptor expression (VEGF, PDGF). Preclinical models show accelerated healing in tendon, muscle, bone, and gastrointestinal tissues.

TB-500 (Thymosin Beta-4 Fragment)

TB-500 sequesters G-actin, promoting cell motility and lamellipodia formation critical for tissue repair. It upregulates VEGF, ILK, and integrins while providing anti-apoptotic effects. The peptide facilitates stem and progenitor cell recruitment to injury sites and modulates immune cells to limit excessive inflammation and fibrosis, resulting in more organized tissue architecture.

Pathway Synergy

Pathway GHK-Cu Role BPC-157 Role TB-500 Role
VEGF/Angiogenesis Moderate activation Strong activation Moderate activation
Collagen Synthesis Primary driver Supportive Minimal
Cell Migration Supportive Strong driver Primary driver
NF-κB/Inflammation Moderate inhibition Strong inhibition Moderate inhibition
ECM Remodeling Primary driver Supportive Supportive

Reconstitution Guidelines for Research Use

Proper reconstitution is essential for maintaining peptide integrity. For researchers sourcing peptides for research France or GLP-1 research peptides EU, follow these validated protocols:

Required Materials

  • Bacteriostatic water (0.9% benzyl alcohol)

  • Sterile 3mL syringe with 18G needle

  • Alcohol prep pads

  • Sterile vial adapter (optional)

Step-by-Step Reconstitution Protocol

  1. Preparation: Allow the lyophilized GLOW 70mg vial to reach room temperature (15 minutes). Clean work surface and wash hands thoroughly.

  2. Sterilization: Wipe the rubber stopper of both the GLOW vial and bacteriostatic water vial with separate alcohol prep pads. Allow to dry completely.

  3. Water Draw: Using a sterile 3mL syringe, draw exactly 3.0mL of bacteriostatic water. This volume yields a final concentration of approximately 23.3 mg/mL .

  4. Injection: Insert the needle through the rubber stopper and inject the bacteriostatic water slowly against the inner glass wall of the vial. Avoid directing the stream directly onto the lyophilized powder to prevent foaming and potential peptide degradation.

  5. Dissolution: Gently swirl or roll the vial between your palms until the solution becomes clear and complete dissolution is observed. Do not shake vigorously as this may denature peptide structure.

  6. Visual Inspection: The final solution should be clear and colorless. Discard if cloudiness, discoloration, or particulates are observed.

  7. Labeling: Record the reconstitution date on the vial label. Store immediately at 2-8°C.

Concentration Reference

  • Total volume: 3.0 mL

  • Final concentration: 23.33 mg/mL

  • Per 0.01 mL (1 unit on U-100 syringe): 233 mcg total blend

  • Per 0.10 mL (10 units): 2,330 mcg (2.33 mg) total blend


Research Applications & Protocol Guidelines

Standard Research Protocol Parameters

Based on published research methodologies for research SARMs and peptide studies:

Parameter Recommendation
Reconstitution Volume 3.0 mL bacteriostatic water
Research Dose Range 2.33 mg total blend daily
Individual Component Per Dose GHK-Cu: ~1.66 mg, TB-500: ~0.33 mg, BPC-157: ~0.33 mg
Administration Route Subcutaneous (research models)
Dosing Frequency Once daily
Typical Study Duration 4 weeks on, 2-4 weeks off
Injection Volume 0.10 mL (10 units on U-100 syringe)

Research Applications by Category

Soft Tissue Repair Studies

  • Tendon and ligament healing investigations

  • Muscle recovery and regeneration research

  • Connective tissue remodeling studies

Dermatological Research

  • Wound healing and closure time studies

  • Collagen synthesis and extracellular matrix research

  • Scar quality and tissue architecture investigations

Gastrointestinal Research

  • Mucosal protection and ulcer healing studies

  • NSAID-induced damage models

  • Intestinal barrier function research

Inflammation Studies

  • Cytokine modulation research

  • NF-κB pathway investigations

  • Oxidative stress and antioxidant studies

Aging and Regeneration Research

  • Cellular senescence studies

  • Extracellular matrix remodeling

  • Tissue quality and tensile strength investigations


Stability Data & Storage Recommendations

Lyophilized (Unreconstituted) Storage

Storage Condition Stability Period Recommendation
-20°C (-4°F) 24+ months Optimal for long-term storage
2-8°C (35.6-46.4°F) 12 months Acceptable for short-term
15-25°C (room temp) 30 days Temporary only during handling
37°C+ Not recommended Accelerated degradation

Reconstituted Solution Storage

Storage Condition Stability Period
2-8°C (refrigerated) 28 days maximum
Room temperature 8 hours maximum
Freezing Not recommended

Critical Storage Guidelines

  • Store lyophilized GLOW 70mg in original packaging away from light and moisture

  • Avoid repeated freeze-thaw cycles of the lyophilized powder

  • Once reconstituted, do not refreeze

  • Protect from direct UV and light exposure during handling

  • Do not store near strong oxidizing agents or acids

  • Label all vials with reconstitution date and researcher initials


Safety Considerations & Handling Protocols

Required Personal Protective Equipment (PPE)

  • Powder-free nitrile gloves

  • Safety goggles or face shield

  • Laboratory coat

  • Closed-toe shoes

Handling Precautions for Research chemicals EU compliant standards

  • Work only in designated laboratory areas with appropriate ventilation

  • Never pipette by mouth

  • Avoid skin, eye, and mucous membrane contact

  • Decontaminate spills immediately with 10% bleach solution

  • Wash hands thoroughly after handling

Theoretical Safety Considerations

Pro-angiogenic Caution: Due to the angiogenic properties of BPC-157 and TB-500, theoretical concerns exist regarding use in research models with active neoplasia or proliferative retinopathies. Investigators should consider this mechanism in study design.

Copper Supplementation: GHK-Cu delivers bioavailable copper. Researchers should note potential interactions in models where copper homeostasis is a variable. Some protocols recommend zinc monitoring in long-term studies.

Contraindications for Research Models:

  • Active malignancy or pre-cancerous conditions

  • Pregnancy or lactation studies without specific ethics approval

  • Severe autoimmune conditions

Waste Disposal

  • Unused peptide solutions: Chemical waste disposal per institutional guidelines

  • Contaminated materials: Biohazard waste

  • Sharps: Approved sharps container

  • Empty vials: Decontaminate before disposal

Emergency Procedures

Exposure Type Action
Skin contact Wash immediately with soap and water for 15 minutes
Eye contact Flush with water for 15 minutes, seek medical evaluation
Inhalation Move to fresh air, seek medical attention if respiratory distress
Ingestion Do not induce vomiting. Seek immediate medical evaluation

Known Research Citations

The following peer-reviewed publications have investigated the individual components of GLOW 70mg:

Wound Healing & Tissue Repair

  • Wound Repair & Regeneration: BPC-157 and TB-500 angiogenesis and cell migration studies

  • Journal of Dermatological Science: Re-epithelialization and tensile strength research

  • Burns: Thermal injury healing acceleration models

Tendon & Ligament

  • American Journal of Sports Medicine: Tendon healing and collagen alignment

  • Journal of Orthopaedic Research: Load-to-failure and biomechanical properties

Dermatology & Aesthetics

  • Clinical, Cosmetic & Investigational Dermatology: Scar quality and remodeling

  • Experimental Dermatology: Elastic fiber organization

  • Journal of Cosmetic Dermatology: Hair follicle and ECM research

Gastrointestinal

  • Gut: Gastric and colonic ulcer healing

  • Pharmacological Reports: NSAID injury protection and anastomosis strength

Neurobiology

  • Frontiers in Neuroscience: Axonal outgrowth studies

  • Neuroscience: Schwann cell migration and nerve repair

Inflammation & Oxidative Stress

  • Skin Pharmacology & Physiology: NF-κB and cytokine modulation

  • Free Radical Biology & Medicine: SOD-mimetic and chelation activity


Why Choose Euresearchpeptides.com for Buy peptides EU

As a premier UE-based online retailer specializing in buy peptides EU, we offer:

  • European Warehousing: Fast, discreet shipping to Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, and all EU member states

  • Verified Purity: Each batch includes Certificate of Analysis with HPLC/MS data

  • EU Regulatory Compliance: Full adherence to research chemicals EU compliant standards

  • Research-Grade Packaging: Lyophilized in sterile vials with tamper-evident seals

  • Dedicated Support: Expert assistance for reconstitution and protocol questions

Whether you require BPC-157 EuropeGLP-1 research peptides EU, or peptide synthesis Europe products, euresearchpeptides.com delivers uncompromising quality for serious researchers.

Q1: Where can I buy GLOW 70mg research peptide blend in Europe?

You can purchase GLOW 70mg directly from euresearchpeptides.com, a trusted buy peptides EU supplier with European warehouse operations. We ship to Germany, France, Netherlands, Spain, and all EU countries. Order now

Q2: What is the composition of GLOW 70mg?

GLOW 70mg contains 50mg GHK-Cu (Copper Tripeptide-1), 10mg TB-500 (Thymosin Beta-4 fragment), and 10mg BPC-157 (Body Protection Compound 157) per vial – a synergistic blend for high purity peptides Germany research applications. View specifications

Q3: How much bacteriostatic water should I use for reconstitution?

Add exactly 3.0mL of bacteriostatic water to the GLOW 70mg vial. This yields a concentration of approximately 23.3 mg/mL, the standard concentration validated in research protocols for peptides for research France studies. Get reconstitution guide

Q4: What is the purity of GLOW 70mg components?

Each peptide component is tested at ≥98% purity by HPLC/MS. Certificates of Analysis are available for every lot, meeting laboratory peptides Netherlands quality standards. Request COA

Q5: How should I store GLOW 70mg before and after reconstitution?

Store lyophilized GLOW 70mg at -20°C (-4°F) for long-term preservation. After reconstitution with bacteriostatic water, refrigerate at 2-8°C (35.6-46.4°F) and use within 28 days – essential for peptide supplier Spain research integrity. Storage guide

Q6: What is the typical research dose for GLOW 70mg?

Standard research protocols utilize 2.33 mg total blend daily (approximately 1.66 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157) for 4-week study periods. This aligns with research SARMs and peptide study methodologies. Dosing protocol

Q7: Is GLOW 70mg compliant with EU research chemical regulations?

Yes. All products including GLOW 70mg are research chemicals EU compliant, supplied strictly for laboratory research use with full documentation and traceability. Compliance info

Q8: Do you ship GLOW 70mg to my country in Europe?

We ship to all EU member countries as a leading BPC-157 Europe and peptide research supplier – including Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, and Denmark. Check shipping

Q9: How quickly will my GLOW 70mg order arrive?

EU orders typically arrive within 3-7 business days. Express shipping options available for GLP-1 research peptides EU and other research supplies. Order today

Q10: What is your quality guarantee for research peptides?

Every product including GLOW 70mg is backed by our quality guarantee with batch-specific HPLC/MS analysis. Contact our support team for any peptide synthesis Europe product concerns. Contact us

Q11: Do I need special equipment to handle GLOW 70mg?

Standard laboratory equipment is sufficient: sterile syringes, bacteriostatic water, alcohol prep pads, and appropriate PPE. We recommend our Research Spray Add-on Kit for complete buy peptides EU accessory needs. View accessories

Q12: How long does reconstituted GLOW 70mg remain stable?

When stored properly at 2-8°C (refrigerated), reconstituted GLOW 70mg remains stable for up to 28 days. Discard any remaining solution after this period to ensure high purity peptides Germany research standards. Stability data

Reviews

There are no reviews yet.

Be the first to review “Glow 70mg (R&D Only)”

Your email address will not be published. Required fields are marked *